AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

AHA Calls on Congress to Defend 340B Access to Specialty, Community Pharmacies Amid Drugmaker Resistance

September 10, 2024 Bella Czajkowski, National Correspondent Views

Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!